Menu Search
Equities

MicroTech Medical Hangzhou Co Ltd

2235:HKG.HS

MicroTech Medical Hangzhou Co Ltd

Actions
  • Price (HKD)3.58
  • Today's Change0.00 / 0.00%
  • Shares traded128.20k
  • 1 Year change-28.40%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MicroTech Medical Hangzhou Co Ltd is a China-based company primarily engaged in the research and development, manufacturing and sale of medical devices. The Company's main business is engaged in the diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management. The Company has the portfolio of products in the field of diabetes monitoring, treatment and management, covering patch insulin pump system, continuous glucose monitoring system (CGMS), closed-loop artificial pancreas system, blood glucose monitoring system (BGMS) products, as well as diabetes digital management software, a number of products on the market and pipeline research. The Company conducts its business in the domestic and overseas markets.

  • Revenue in HKD (TTM)273.38m
  • Net income in HKD-134.96m
  • Incorporated2011
  • Employees760.00
  • Location
    MicroTech Medical Hangzhou Co LtdNo. 108 Liuze StreetCangqian Street, Yuhang DistrictHANGZHOU ChinaCHN
  • Websitehttps://www.microtechmd.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.